Feb 27, 2025 / 01:30PM GMT
Operator
Good day, ladies and gentlemen, and welcome to Altimmune fourth quarter and full year 2024 financial results conference call. As a reminder, this call is being recorded. (Operator Instructions)
I would now like to introduce your host for today's conference call, Lee Roth, President of President, Burns Mcclellan Investor Relations, advisor to Altimmune. Lee, you may begin.
Lee Roth - Burns Mcclellan - President, Investor Relations
Thanks Gigi. Good morning everyone, and once again thank you all for joining us for Altimmune fourth quarter and full year 2024 financial results and business update conference call.
On today's call, you'll hear from Dr. Vipin Garg, our Chief Executive Officer, Dr. Scot Harris, our Chief Medical Officer, and Greg Weaver, our Chief Financial Officer. Dr. Scott Roberts, our Chief Scientific Officer, and Ray Jordt, our Chief Business Officer, will join us for the Q&A session.
Press release covering our fourth quarter and full year 2024 financial results and corporate update was issued earlier this morning
Q4 2024 Altimmune Inc Earnings Call Transcript
Feb 27, 2025
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers